A. Notarpaolo

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.

F. Roudot-thoraval, S. Katsahian, E. Audureau, 2017, Journal of hepatology.

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2022, JHEP reports : innovation in hepatology.

Impact of locoregional therapy on post-transplant outcomes in patients with hepatocellular carcinoma beyond Milan criteria

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2021, JHEP Reports.

AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2022, JHEP reports : innovation in hepatology.

P915 PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT

F. Roudot-thoraval, S. Katsahian, C. Duvoux, 2014 .

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2021, JHEP reports : innovation in hepatology.